Memorial Sloan Kettering Cancer Center

“I like my hair, and I didn’t want to lose it. I didn’t want to go through my senior year bald." Cody spent the summer before his senior year of high school recovering from a major operation at MSK Kids to treat metastatic kidney cancer. His treatment also included a clinical trial, which allowed Cody to avoid chemotherapy (and potential hair loss) and graduate from high school on time. Two and a half years after starting alectinib, he still takes the pills twice a day, but now has no evidence of disease. The drug causes some side effects, but Cody is now a 19-year-old sophomore studying criminal justice and continues participating in his favorite activities, especially bowling. Cody is part of MSK’s Gen:C (Generation Cancer) campaign, which showcases what it’s like for a young person to deal with one of life’s most difficult challenges: a cancer diagnosis. Read more about Cody's story and his treatment: https://bit.ly/3EhqvOm

In the latest episode of the Cancer Straight Talk podcast, host Dr. Diane Reidy-Langunes speaks with experts at Memorial Sloan Kettering Cancer Center (MSK) about how cancer patients can preserve their fertility. 🎙️Listen to the full episode for insights and more inspiring stories from survivors and new parents: https://bit.ly/4aEmrDV MSK’s Gen:C (Generation Cancer) campaign showcases what it’s like for a young person to deal with cancer on top of daily challenges, including a fertility journey. We encourage you to share your own story in the comments below. #GenC.

Experts from Memorial Sloan Kettering Cancer Center (MSK), including gastrointestinal oncologist Dr. Ghassan Abou-Alfa, share research at the Arab Health Exhibition in Dubai. Learn more: https://bit.ly/4h98Ary #ArabHealth

Memorial Sloan Kettering Cancer Center (MSK) is committed to developing and promoting solutions that improve the ways that clinical research happens around the globe. One way is through data accuracy and operational efficiencies. In a recent presentation to the FDA's Center for Drug Evaluation & Research Health IT Board, Michael Buckley, Associate Director for MSK's Clinical Research Information & Technology (CRIT), reported results from a real-world mirror study of the impact of electronic health record (EHR) to electronic data capture (EDC) technology. Significant findings included a 99% reduction in data entry errors through the use of electronic rather manual data entry methods. Meanwhile, MSK’s switch to electronic data entry in this study raised productivity levels among data managers by nearly 60%. “We work closely with our peers in academia, biopharma, consortiums, and the FDA to accelerate the adoption of healthcare data standards for clinical research,” Michael explains. Learn more about this research: https://bit.ly/3CtqLsY

Researchers from Memorial Sloan Kettering Cancer Center (MSK) are key contributors to an ambitious new project called The Human Virome Program. Funded by the National Institutes of Health (NIH), the project seeks to map the many viruses that are part of the body’s ecosystem and aims to understand how this collection of viruses — known as the virome — may influence human health in unexpected ways. “There are more individual viruses on earth than stars in the universe," says MSK computational biologist Dr. Caleb Lareau, who was recently awarded a five-year $5 million grant to work on the project. “But the big questions are about how the various viruses you have been exposed to, combined with your unique genetic fingerprint and other factors, influence your likelihood of developing different diseases — including cancer.” Dr. Lareau and his team will develop techniques to analyze sequencing data from hundreds of thousands of individuals to identify and quantify virus signatures found in their bodies with the goal to reveal potential health outcomes. Learn more about this exciting new effort: https://bit.ly/3E6nnVg

Hear from Dr. Saad Z. Usmani, a hematologist-oncologist at Memorial Sloan Kettering Cancer Center (MSK), as he speaks about research on multiple myeloma.

Memorial Sloan Kettering Cancer Center (MSK) is on the ground at the Arab Health Exhibition this week in Dubai. Follow along for updates from our experts.

Experts from Memorial Sloan Kettering Cancer Center (MSK), including breast medical oncologist Dr. Larry Norton, share research at the Arab Health Exhibition in Dubai. Learn more: https://bit.ly/4h98Ary #ArabHealth

After listening to Dr. Joan Massagué, Director of the Sloan Kettering Institute and Chief Scientific Officer at Memorial Sloan Kettering Cancer Center (MSK), speak at a conference, neuro-oncologist Dr. Adrienne Boire became so inspired by his research that she came to work with him at MSK. Here, she discusses that decision, as well as the parallel between science and another passion — knitting, a primary way Dr. Boire decompresses, resets, and clears her mind for discovery. Read more about Dr. Boire, who is also the Scientific Director of the Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center: https://bit.ly/42nWcj1

“As one of the largest pediatric cancer programs in the United States, [Memorial Sloan Kettering Cancer Center (MSK) Kids] is dedicated to delivering the best possible treatment for each child and learning from their experience to help others,” says Dr. Andrew Kung, Chair of the Department of Pediatrics. Read more about the notable advances for MSK Kids in 2024, including earning authorization to provide the first gene therapy for sickle cell disease and beta thalassemia, opening a new program for patients with desmoplastic small round cell tumors, and more: https://bit.ly/4gbICSQ